Trial Profile
Phase III trial of abuse-resistant oxycodone [Remoxy; Pain Therapeutics] in patients with moderate to severe osteoarthritis pain.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Cassava Sciences; King Pharmaceuticals; Pain Therapeutics
- 20 Aug 2008 Results presented at 12th World Congress of the International Association for the Study of Pain (IASP) in August 2008.
- 07 Dec 2007 Status changed from in progress to completed.
- 06 Dec 2007 Preliminary data available; primary endpoint achieved. Pain Therapeutics expect to file a New Drug Application to the US FDA in the second quarter of 2008, based on the results of this trial.